Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antidepressants in Bipolar Maintenance
NCT00958633Phase 3Terminated
- Sponsor
- University of British Columbia
- Start
- Nov 2010
- Primary completion
- Mar 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of escitalopram, bupropion in bipolar I disorder, sponsored by University of British Columbia. Started Nov 2010; status: terminated.
02
Drugs
escitaloprambupropion
03
Conditions
bipolar I disorder
Beyond the preview
Go deeper on NCT00958633.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00958633.